NCT04049461View on ClinicalTrials.gov

Heterotopic Ossification in Abdominal Incision and Pancreatic Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

105

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2025

Conditions
Cancer of PancreasOssification, Heterotopic
Interventions
DIAGNOSTIC_TEST

Bone alkaline phosphatase

Hematologic indicators reflecting ossification.

RADIATION

Abdominal CT scan

Observe whether HOAI occurs.

Trial Locations (1)

210029

The first affiliated hospital of Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER